User profiles for Pokrath Hansasuta
Pokrath HansasutaChulalongkorn University Verified email at Chula.ac.th Cited by 2058 |
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
…, N Gudgeon, NE Annels, P Hansasuta… - The Journal of …, 1999 - journals.aai.org
EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive (lytic)
infections within the cells of its host. Although T cell responses to EBV latent proteins …
infections within the cells of its host. Although T cell responses to EBV latent proteins …
Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific
P Hansasuta, T Dong, H Thananchai… - European journal of …, 2004 - Wiley Online Library
The recognition of MHC class I molecules by killer cell immunoglobulin‐like receptors (KIR)
is central to the control of NK cell function and can also modulate the CTL activation …
is central to the control of NK cell function and can also modulate the CTL activation …
Dynamics of T cell responses in HIV infection
…, L Papagno, CA Spina, P Hansasuta… - The Journal of …, 2002 - journals.aai.org
Cytotoxic CD8+ T cells play a major role in the immune response against viruses. However,
the dynamics of CD8+ T cell responses during the course of a human infection are not well …
the dynamics of CD8+ T cell responses during the course of a human infection are not well …
Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
…, D Kannarunimit, P Hansasuta… - Journal of Radiation …, 2017 - academic.oup.com
Epstein-Barr virus (EBV) DNA has been recognized as a promising tumor marker for
nasopharyngeal carcinoma (NPC). This study aims to demonstrate the prevalence of plasma EBV …
nasopharyngeal carcinoma (NPC). This study aims to demonstrate the prevalence of plasma EBV …
Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection
…, CN Nichols, S Pinyakorn, P Hansasuta… - Science translational …, 2017 - science.org
CD8 + T cells play a critical role in controlling HIV viremia and could be important in reducing
HIV-infected cells in approaches to eradicate HIV. The simian immunodeficiency virus …
HIV-infected cells in approaches to eradicate HIV. The simian immunodeficiency virus …
Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome
Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) probably play
the major role in controlling HIV replication. However, the value of adoptive transfer of HIV-…
the major role in controlling HIV replication. However, the value of adoptive transfer of HIV-…
[HTML][HTML] Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count< 200 …
…, T Apornpong, SJ Kerr, P Hansasuta… - Journal of Virus …, 2020 - Elsevier
Background Complete recovery of the CD4 T cell count is uncommon among chronically HIV-infected
individuals with very low pre-treatment CD4 count. We studied the prevalence of …
individuals with very low pre-treatment CD4 count. We studied the prevalence of …
HIV-1 transmission and acute HIV-1 infection
P Hansasuta, SL Rowland-Jones - British medical bulletin, 2001 - academic.oup.com
An understanding of the central events in the transmission of HIV-1 infection is critical to the
development of effective strategies to prevent infection. Although the main routes of …
development of effective strategies to prevent infection. Although the main routes of …
Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy
…, S Kitpanit, C Chakkabat, P Hansasuta… - Japanese Journal of …, 2018 - academic.oup.com
Objective Plasma Epstein–Barr virus (EBV) DNA concentration at the time of diagnosis (pre-EBV)
can be used to stratify risk for nasopharyngeal cancer (NPC) patients. However, pre-…
can be used to stratify risk for nasopharyngeal cancer (NPC) patients. However, pre-…
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors
HIV-specific cytotoxic T-lymphocytes (CTL) are believed to play a key part in the control of
virus levels throughout HIV infection. An important goal of a potential prophylactic vaccine …
virus levels throughout HIV infection. An important goal of a potential prophylactic vaccine …